It is an antidepressant that is a member of the class of medications known as selective serotonin reuptake inhibitors (SSRIs). Its liver breaks it down, and 94–95 per cent of it binds to proteins. Fluoxetine is an antidepressant medication. It is used to treat depression as well as other mental health conditions including panic disorder and obsessive-compulsive disorder. These include compulsions to engage in undesired thoughts and repetitive behaviours as well as anxious feelings and fast breathing and heart rate. This drug works by increasing the levels of a chemical substance in your brain, which helps to stabilise your mood and sense of well-being. Fluoxetine may cause common side effects such as headaches, nausea, lack of appetite, agitation, anxiety, dizziness, fatigue, and excessive sweating. It is used to treat a variety of diseases, including bulimia, depression, panic attacks, obsessive-compulsive disorder, and a severe type of premenstrual syndrome. This medication assists patients in returning to their regular routines by improving sleep, mood, appetite, and energy levels while lowering anxiety, unpleasant thoughts, fear, and panic attacks.
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College and NEALAC Clinic , United States
Title : The effect of Balint training on self-efficacy and empathy among medical students and the moderator role of personality traits and choice of specialty
Meni Koslowsky, Ariel University, Israel
Title : Sexualizing anxiety and anxiolytic sex: Misattribution of arousal
Sam Vaknin, Commonwealth Institute of Advanced Professional Studies, United Kingdom
Title : Dr Jekyll and Mr. Hyde revealed: Tales from the default mode network
Christopher Ashton, TeDDs on Chapel, Centre for Recovery, Canada
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Addiction and the failure of meaning-forming
Jenni Guentcheva, GoodNeighbor LLC, United States